🇺🇸 Halometasone Triclosan in United States
11 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 11
Most-reported reactions
- Drug Eruption — 2 reports (18.18%)
- Acne — 1 report (9.09%)
- Anaphylactic Reaction — 1 report (9.09%)
- Condition Aggravated — 1 report (9.09%)
- Conjunctival Hyperaemia — 1 report (9.09%)
- Covid-19 — 1 report (9.09%)
- Deafness Bilateral — 1 report (9.09%)
- Drug Ineffective — 1 report (9.09%)
- Dry Skin — 1 report (9.09%)
- Erythema — 1 report (9.09%)
Other Dermatology approved in United States
Frequently asked questions
Is Halometasone Triclosan approved in United States?
Halometasone Triclosan does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Halometasone Triclosan in United States?
Beijing Friendship Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.